The Lancet Haematology · 2019 · 140 citations · 22 references
MedicinePharmacologyPharmacotherapyClinical PharmacologyAnticoagulant ManagementAnticoagulant TherapyObesity ManagementPharmacoepidemiologyThrombosis PreventionChart AuditingObesity-associated ThrombosisPharmacotherapy For Severe ObesityWarfarin Toxicity
22
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
Stuart J. Connolly, Michael D. Ezekowitz, Salim Yusuf et al. · New England Journal of Medicine · 2009 · 11.2K citations · Full text
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel, Kenneth W. Mahaffey, Jyotsna Garg et al. · New England Journal of Medicine · 2011 · 9.4K citations · Full text
Apixaban versus Warfarin in Patients with Atrial Fibrillation
Christopher B. Granger, John H. Alexander, John J.V. McMurray et al. · New England Journal of Medicine · 2011 · 8.9K citations · Full text
Oral Rivaroxaban for Symptomatic Venous Thromboembolism
New England Journal of Medicine · 2010 · 3.2K citations · Full text